In a large-animal model study, researchers have found that heart attack recovery is aided by injection of heart muscle cell spheroids derived from human induced pluripotent stem cells, or hiPSCs, that ...

GlobalData has named heart failure as the next disease to feel the sales-boosting power of GLP-1 drugs. The analysts expect ...

RyCarma Therapeutics, Inc., formerly known as ARMGO Pharma (the "Company" or "RyCarma"), a clinical-stage biotech company developing first-in-class small molecule therapeutics for cardiovascular and ...

GlobalData expects that the US will contribute the most to the growth of the heart failure market due to the higher ...

More than two billion people worldwide live with overweight or obesity, conditions closely linked to an array of health ...

Interactions with friends and family may keep us healthy because they boost our immune system and reduce our risk of diseases such as heart disease, stroke and type 2 diabetes, new research suggests.

Shares of Mesoblast Limited MESO have soared 80% in one month following the FDA approval of remestemcel-L as the only ...

The presence of CVD may increase the risk of developing dementia among older patients with RA, though CVD was not found to ...

Ischemic heart disease (IHD) remains the leading cause of mortality globally, despite advancements in pharmacotherapy and revascularization techniques that ...

Scientists from The Second Affiliated Hospital of Zhejiang University have found evidence suggesting a possible causal ...

Heart Failure, Pathophysiology, Etiology, Reduced Ejection Fraction, Preserved Ejection Fraction, Revascularization, CABG, ...

The review suggests that inadequate magnesium levels can increase the risk for cardiovascular disease, based on data from ...